(a) No later than April 1, 2023, each pharmacy, private label distributor, and repackager that sells or offers for sale in Illinois, under its own label, a covered drug must provide written notification to the Agency identifying the covered manufacturer from which the covered drug is obtained. (b) All covered manufacturers of covered drugs sold or offered for sale in Illinois must register with the Agency and pay to the Agency the annual registration fee as set forth under Section 60.
410 ILCS 720/20
Identification of covered manufacturers
Known as the Drug Take-Back Act
The act spans §§ 410-720-1 to 410-720-999 (20 sections).
P.A. 102-1055, eff. 6-10-22.
Official source: Illinois General Assembly. Reproduced from public-domain Illinois statutes; confirm against the official source for the current text. Not legal advice.